Tag:
Daliresp
Latest Headlines
Latest Headlines
Forest, Nycomed win narrow FDA approval on new COPD drug
Forest Labs and Switzerland's Nycomed have managed to overcome some sharp criticism from a panel of experts and win a narrow approval of Daliresp (roflumilast) to prevent the exacerbation of COPD.
